Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti‑inflammatory drug presented as an oral formulation for oral use. It reduces inflammation and pain in musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and in acute pain episodes.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics across global markets. Our network facilitates timely delivery, batch traceability, and support for pharmacovigilance activities, meeting the needs of diverse healthcare providers.

Movalis, a meloxicam NSAID, acts on inflammatory pathways to relieve symptoms in several musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and improves mobility in patients with degenerative joint disease. - Rheumatoid arthritis: alleviates inflammatory joint pain and swelling in autoimmune arthritis. - Ankylosing spondylitis: diminishes spinal inflammation and associated discomfort in axial spondyloarthritis. - Acute pain: provides short‑term relief of moderate to severe pain from various causes.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or vertigo. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Peptic ulcer or gastrointestinal bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic dysfunction including elevated enzymes or hepatitis. - Severe skin reactions like Stevens‑Johnson syndrome.

When prescribing or dispensing Movalis, several precautions should be observed to minimize risk.

- Assess renal function: evaluate kidney health before initiating therapy and monitor periodically. - Evaluate cardiovascular risk: consider history of heart disease or stroke before use. - Use lowest effective dose: prescribe the minimal dose needed for symptom control. - Avoid in active gastrointestinal ulceration: contraindicated in patients with current peptic ulcers. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Lithium: elevated lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: risk of reduced kidney perfusion. - Methotrexate: potential increase in methotrexate toxicity.